Browsing Tag
Department of War
17 posts
Leidos (NYSE: LDOS) stock faces defence re-rating test as hypersonics and low-cost missile deals reshape growth story
Leidos has fresh missile catalysts, but LDOS still trades far below its high. The real test is whether production scale changes the story.
May 17, 2026
DoW missile agreements put Leidos, Anduril, and Castelion at the centre of America’s strike-capacity reset
America needs missile mass faster than legacy procurement can deliver. DoW’s new deals show how defence production is being rewired.
May 17, 2026
Elsight (ASX: ELS) stock up 11.02% as Halo Blue UAS clearance drives 12x revenue surge
Modern drones need bulletproof comms in jammed airspace. Elsight (ASX: ELS) just cleared the US Blue UAS List and grew revenue twelve-fold. The procurement story is now real.
May 15, 2026
L3Harris wins US Air Force ABMS digital backbone role as LHX trades 21% off 52-week high
The Air Force just gave L3Harris the ABMS backbone. The harder question is whether LHX, down 21% from highs, can convert this into multi-year backlog.
May 9, 2026
Why Donald Trump’s UFO file release has reopened America’s transparency fight
UFO files are public, but certainty is not. Donald Trump’s release turns a secrecy debate into a test of United States trust.
May 9, 2026
LMT stock falls 4.6% on Q1 2026 earnings miss as Lockheed Martin’s free cash flow swings to minus $291m
Lockheed Martin Q1 2026 EPS of $6.44 missed estimates as margins fell across three segments. Full-year guidance reaffirmed. Read the full analysis.
April 24, 2026
Why acute stress disorder may become the next major neuroscience opportunity for BXCL501
Could BXCL501 open a major new neuroscience market in acute stress disorder? Read what this means for BioXcel Therapeutics and investors.
April 10, 2026
Lockheed Martin (LMT) bags $4.7bn PAC-3 MSE contract as U.S. pushes missile production to record highs
Lockheed Martin secures a $4.7bn PAC-3 MSE accelerated production contract. Here's what it means for LMT stock, allied air defence, and the defence sector. Read more.
April 10, 2026
Is Firefly Neuroscience, Inc. building a scalable AI diagnostics platform through U.S. defense healthcare partnerships? (NASDAQ: AIFF)
Firefly Neuroscience, Inc. enters defense healthcare with AI brain tech. Find out how this partnership could reshape neurodiagnostics markets.
March 26, 2026
US strikes 9,000 Iran targets, Pentagon now scrambles to refill missiles
The Pentagon signed framework agreements with Lockheed Martin, BAE Systems and Honeywell Aerospace on 25 March 2026 to expand United States munitions production.
March 26, 2026